Related Experiment Video
Updated: Mar 30, 2026

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
Published on: November 18, 2022
Decentralized Chronic Care Service Delivery for People Living with Type 1 Diabetes in Low- and Lower-Middle-Income
Whitney Puetz1, Chris Noble2, Laura Drown1
1Center for Integration Science in Global Health Equity, Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Objective:
The objective of this scoping review is to examine the published literature on the organization of type 1 diabetes care provision at primary and first-referral (generally district hospital level) facilities in low and lower-middle-income countries (LLMICs).
Methods:
This scoping review searched 8 databases for published literature (2000-2024) describing service delivery for people living with type 1 diabetes in LLMICs at lower-level health facilities, resulting in 46 papers describing 40 studies.
Results:
Many studies include missing data, but available evidence suggests a lack of priority supplies and activities including ability to self-monitor blood glucose, basal-bolus insulin regimes, and A1C tests. Many studies reported specialized models, with diabetes clinics housed in outpatient departments, chronic care units, or noncommunicable disease clinics. Integrated approaches included diabetes care integrated into noncommunicable disease clinics or chronic care clinics, whereas nondifferentiated care in outpatient departments was reported in 2 studies. In one third of studies, clinic location could not be determined. Clinics were commonly staffed by midlevel providers, with variable reporting on training and mentoring. Patient education was described in most studies.
Conclusion:
This review found a lack of evidence for critical components of intermediate diabetes management at most clinics in LLMICs, namely, the ability to self-monitor blood glucose, A1C testing, basal-bolus insulin regimens, peer support, social support, and comprehensive complication screening. The results of our review highlight both the urgent need for escalation to intermediate care in LLMICs and a need for standardized minimum reporting standards.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...

